Evolution of Maternal and Paternal-fetus Attachment in Egg Donation
Assessing the Evolution of Maternal and Paternal-fetus Attachment in Couples Conceiving Through Egg Donation
1 other identifier
observational
132
3 countries
3
Brief Summary
Recently, many families have been formed through gamete donation, a reproductive treatment where the ensuing children do not share a genetic link with either parents. However, despite such an increase, little is known about the parent-child relationship. Indeed, only two longitudinal studies have provided scientific background about family functioning in gamete donation. These studies showed that in egg donation families, the parent-child relationship was normal for parenting, parent psychological health, and child adjustment. A more recent study evaluated mother-infant interaction in egg donation families comparing them with those created through IVF with their own gametes. Data collected showed that in egg donation families the mother-infant relationship quality appeared to be less optimal. Mothers were less interactive and stimulating, and infants showed lower involvement and less responsiveness with respect to their mothers Overall, the evidence suggests that women conceiving through egg donation likely require a variable period of adaptation to parenting. Here, the investigators aim to evaluate this interaction at an earlier stage, that is during the gestation. The specific bond that parents develop towards the fetus during pregnancy is called "parental-fetus attachment". Previous studies showed that the quality of the parental-fetus attachment is predictive of the quality of the postnatal parent-infant relationship and the child development The purpose is to evaluate whether the lack of genetic link with their offspring could undermine the parental attachment to the fetus, comparing couples conceiving through egg donation with those who get pregnant through a standard IVF treatment with their own gametes. No studies have been performed so far on this matter. To assess the mother-father fetus attachment, the investigators will administer standardized and validated questionnaires to couples undergoing IVF with their own gametes, or egg donation cycles. For women, the investigators will use the Maternal Antenatal Attachment Scale . For men, the investigators will use the Paternal Antenatal Attachment Scale (PAAS-IT) . Furthermore, to also assess the emotional status of both partners, the investigators will use the Matthey Generic Mood Questionnaire . Seeing that in the general population the maternal-fetal attachment level increases once women have completed the principal prenatal genetic screenings (like NIPT, CVS or amnio) and once they start perceiving the fetal movements, the investigators will administer the same questionnaire twice: between the 19-23 weeks and between the 28-32 weeks of gestation. This approach will enable monitoring of the evolution of the maternal and paternal fetal attachment at relevant gestational time-points. As a result of the knowledge gathered from this study, the investigators will be able to develop a specific intervention strategy to promote this fundamental process for egg donation families.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Nov 2022
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2022
CompletedFirst Submitted
Initial submission to the registry
May 11, 2023
CompletedFirst Posted
Study publicly available on registry
June 8, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
March 30, 2024
CompletedFebruary 26, 2025
May 1, 2023
1.4 years
May 11, 2023
February 25, 2025
Conditions
Outcome Measures
Primary Outcomes (3)
validated questionnaire to assess the change of maternal fetus attachment (MAAS)
The MAAS total score is calculated by the sum of all item of the questionnaire, and the subscales score (quality and intensity of the attachment) are calculated through the sum of the rate of each item that is included in that scale. Scoring is 1-5, with 5 high attachment
between 19-23 gestational weeks and follow up between 28-32 weeks of gestation
validated questionnaire to assess the change of Paternal fetus attachment (PAAS)
The PAAS total score is calculated by the sum of all item of the questionnaire, and the subscales score (quality and intensity of the attachment) are calculated through the sum of the rate of each item that is included in that scale. Scoring is 1-5, with 5 high attachment
between 19-23 gestational weeks and follow up between 28-32 weeks of gestation
questionnaire to explore the change of the Emotional status (Anxiety or depression feelings) during pregnancy (MGMQ)
The MGMQ provideds a screen positive / negative classification of emotional distress
between 19-23 gestational weeks and follow up between 28-32 weeks of gestation
Study Arms (2)
DONATED GAMETE GROUP
couples who got pregnant through egg donation (with their own semen)
OWN GAMETE GROUP
couples who got pregnant through standard IVF treatment, with their own gametes
Interventions
Eligibility Criteria
The reference population includes all couples who have become pregnant in the selected IVI RMA clinics , through egg donation or standard IVF treatment, being the woman 40 years old or above, with no other specific indications (except individuals taking psychotropic drugs). Their native language must be English or Italian.
You may qualify if:
- getting pregnant through an egg donation program
- Own semen
- Native language must be English or Italian
You may not qualify if:
- Patients failing to consent to be recontacted for research purpose.
- Patients who are taking psychotropic drugs
- Patients who got pregnant through sperm or embryo donation
- OWN GAMETE GROUP
- getting pregnant through a standard IVF treatment with own gametes
- Native language must be English or Italian
- Patients failing to consent to be recontacted for research purpose.
- Patients who are taking psychotropic drugs
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Fundación IVIlead
Study Sites (3)
IVI Roma
Roma, 00169, Italy
IVI Foundation
Valencia, 46026, Spain
IVI London
London, W1G 9RQ, United Kingdom
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 11, 2023
First Posted
June 8, 2023
Study Start
November 1, 2022
Primary Completion
March 30, 2024
Study Completion
March 30, 2024
Last Updated
February 26, 2025
Record last verified: 2023-05